As for predictors of clinical outcome, DM and previous MI history increased the risk of all-cause death, while usage of aspirin and angiotensin-converting enzyme inhibitor (ACEI) would reduce the risk of all-cause death. This evidence concerns the gene ACE and myocardial infarction.